Amarin Corp Plcuk (AMRN) Amortizatization of Intangibles (2012 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Amortizatization of Intangibles of $637000.0 for Q1 2026, down 47.62% YoY from $1.2 million in Q1 2025, and down 9.13% sequentially from $701000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Amortizatization of Intangibles (2012 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Amortizatization of Intangibles across 15 years of filings, most recently posting $637000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 47.62% year-over-year to $637000.0; the TTM figure through Mar 2026 stood at $2.4 million (down 27.81% YoY), while the FY2025 annual figure was $3.0 million, up 4.28% from the prior year.
  • Amortizatization of Intangibles eased to $637000.0 in Q1 2026, from $701000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for AMRN reached as high as $2.0 million in Q2 2024 and fell as low as -$2.4 million in Q4 2022.
  • The 5-year median for Amortizatization of Intangibles is $701000.0 (2023), against an average of $523117.6.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 342.51% — and 2024, when it slumped 280.17%.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$2.4 million in 2022, then surged by 129.43% to $701000.0 in 2023, then tumbled by 280.17% to -$1.3 million in 2024, then surged by 155.5% to $701000.0 in 2025, then dropped by 9.13% to $637000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $637000.0, $701000.0, and $134000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 1.70 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 931.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 596.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 637,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 637,000.00
Mar 31, 2026 637,000.00
Dec 31, 2025 701,000.00
Dec 31, 2025 701,000.00
Sep 30, 2025 134,000.00
Sep 30, 2025 134,000.00
Jun 30, 2025 973,000.00
Jun 30, 2025 973,000.00
Mar 31, 2025 1.22 Mn
Mar 31, 2025 1.22 Mn
Dec 31, 2024 -1.26 Mn
Dec 31, 2024 -1.26 Mn
Sep 30, 2024 1.42 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 2.02 Mn
Jun 30, 2024 2.02 Mn
Mar 31, 2024 729,000.00
Mar 31, 2024 729,000.00
Dec 31, 2023 701,000.00
Dec 31, 2023 701,000.00